RenovoRx, Inc.

NasdaqCM:RNXT Stock Report

Market Cap: US$31.3m

RenovoRx Management

Management criteria checks 2/4

RenovoRx's CEO is Shaun Bagai, appointed in Jun 2014, has a tenure of 11.5 years. total yearly compensation is $1.23M, comprised of 42.4% salary and 57.6% bonuses, including company stock and options. directly owns 0.93% of the company’s shares, worth $290.63K. The average tenure of the management team and the board of directors is 4.2 years and 7.4 years respectively.

Key information

Shaun Bagai

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage42.41%
CEO tenure11.5yrs
CEO ownership0.9%
Management average tenure4.2yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation

Aug 16
Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation

RenovoRx (NASDAQ:RNXT) Is Revolutionizing Cancer Treatment

May 26
RenovoRx (NASDAQ:RNXT) Is Revolutionizing Cancer Treatment

Revolutionizing Cancer Treatment

A small incision is made in the leg to insert the RenovoCath® system.

RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount

Feb 05

We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully

Oct 26
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully

Is RenovoRx (NASDAQ:RNXT) In A Good Position To Invest In Growth?

Mar 31
Is RenovoRx (NASDAQ:RNXT) In A Good Position To Invest In Growth?

Companies Like RenovoRx (NASDAQ:RNXT) Could Be Quite Risky

Dec 16
Companies Like RenovoRx (NASDAQ:RNXT) Could Be Quite Risky

RenovoRx reports Q2 results

Aug 15

Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

Aug 04
Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

RenovoRx names new finance CFO

Jul 19

RenovoRx (NASDAQ:RNXT) Is In A Good Position To Deliver On Growth Plans

Mar 16
RenovoRx (NASDAQ:RNXT) Is In A Good Position To Deliver On Growth Plans

We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth

Nov 30
We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Shaun Bagai's remuneration changed compared to RenovoRx's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$11m

Jun 30 2025n/an/a

-US$11m

Mar 31 2025n/an/a

-US$10m

Dec 31 2024US$1mUS$520k

-US$9m

Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$939kUS$520k

-US$10m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$10m

Dec 31 2022US$841kUS$495k

-US$10m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$988kUS$323k

-US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$4m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$253kUS$253k

-US$4m

Dec 31 2019US$270kUS$240k

-US$4m

Compensation vs Market: Shaun's total compensation ($USD1.23M) is above average for companies of similar size in the US market ($USD576.00K).

Compensation vs Earnings: Shaun's compensation has increased whilst the company is unprofitable.

CEO

Shaun Bagai (48 yo)

11.5yrs
Tenure
US$1,226,050
Compensation

Mr. Shaun R. Bagai has been the Chief Executive Officer and Director of RenovoRx, Inc. since June 2014. He is Secretary at RenovoRx, Inc. He joined RenovoRx in June 2014 and in his first few months has bee...

Leadership Team

NamePositionTenureCompensationOwnership
Ramtin Agah
Founder7.6yrsUS$603.02k2.12%
$ 665.3k
Shaun Bagai
CEO, Secretary & Director11.5yrsUS$1.23m0.93%
$ 290.6k
Leesa Gentry
Chief Clinical Officerno dataUS$890.15k0%
$ 0
Robert Strasser
Vice President of Operations and R&D1.1yrsno datano data
Ronald Kocak
VP, Controller & Principal Accounting Officer4.2yrsno data0.034%
$ 10.7k
Ryan Witt
Senior VP and Head of Corporate Strategy & Partnerships1.5yrsno datano data
4.2yrs
Average Tenure
57yo
Average Age

Experienced Management: RNXT's management team is considered experienced (4.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ramtin Agah
Founder7.6yrsUS$603.02k2.12%
$ 665.3k
Shaun Bagai
CEO, Secretary & Director11.5yrsUS$1.23m0.93%
$ 290.6k
Una Ryan
Independent Director12.9yrsUS$88.79k0%
$ 0
Lawrence Marton
Independent Director13yrsUS$76.78k0.18%
$ 56.6k
Margaret Tempero
Member of Scientific Advisory Board2.5yrsno datano data
Robert Jay Spiegel
Independent Director2.7yrsUS$75.37k0.11%
$ 35.0k
Kirsten MacFarlane
Independent Director7.3yrsUS$79.28k0.11%
$ 35.0k
Timothy Donahue
Member of Scientific Advisory Boardless than a yearno datano data
Michael Pishvaian
Member of Advisory Board8.4yrsno datano data
Karyn Goodman
Member of Advisory Board8.4yrsno datano data
Thierry De Baere
Member of Scientific Advisory Boardless than a yearno datano data
Michel Ducreux
Member of Scientific Advisory Board2.1yrsno datano data
7.4yrs
Average Tenure
68.5yo
Average Age

Experienced Board: RNXT's board of directors are considered experienced (7.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/28 10:28
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RenovoRx, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Edward WooAscendiant Capital Markets LLC
Swayampakula RamakanthH.C. Wainwright & Co.